# HEMOBIOTECH, INC.: Form D filings

HEMOBIOTECH, INC., a pharmaceuticals company in Dallas, TX, filed 2 Form D notices with the SEC between 2009 and 2010. The latest, on January 25, 2010, reports an offering of $3.5 million with nothing sold yet.

Find out what HEMOBIOTECH, INC. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20HEMOBIOTECH%2C%20INC.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=HEMOBIOTECH%2C%20INC.&page=%2Fdata%2Fform-d%2Fcompany%2Fhemobiotech-inc-1301348)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20HEMOBIOTECH%2C%20INC.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=HEMOBIOTECH%2C%20INC.&page=%2Fdata%2Fform-d%2Fcompany%2Fhemobiotech-inc-1301348)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Texas](https://specstream.ai/data/form-d/state/texas): 4,800 rows, by operating companies, filed since November 1, 2024, $128, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/texas
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 5001 SPRING VALLEY ROAD, SUITE 1040 - WEST, Dallas, TX, 75244
- Phone: (972) 455-8950
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: No Revenues
- Exemptions claimed: Rule 506
- SEC identifier (CIK): 1301348

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Jan 25, 2010 | New notice | $3,500,000 | $0 | $3,500,000 | 0 | Yet to occur | [sec.gov](https://www.sec.gov/Archives/edgar/data/1301348/000144373910000001/0001443739-10-000001-index.htm) |
| Nov 4, 2009 | New notice | $350,000 | $160,000 | $190,000 | 5 | Oct 14, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1301348/000141102309000008/0001411023-09-000008-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Robert Comer | Executive Officer, Director |  |
| Bernhard Mittemeyer | Director |  |
| Ghassan Nino | Director |  |
| Robert Baron | Director |  |
| Robert Dragoo, Jr. | Director |  |
| Arthur Bollon | Executive Officer, Director |  |

## Other pharmaceuticals companies in Texas that filed recently

- [LUCIER PHARMACEUTICALS INC](https://specstream.ai/data/form-d/company/lucier-pharmaceuticals-inc-2158290) offering · Oct 13, 2026
- [FibroBiologics, Inc.](https://specstream.ai/data/form-d/company/fibrobiologics-inc-1958777) $1.2 million · Oct 13, 2026
- [Eos SENOLYTIX, Inc.](https://specstream.ai/data/form-d/company/eos-senolytix-inc-2129803) $750,000 · Aug 27, 2026

[Every Form D from the week of Jan 25, 2010](https://specstream.ai/data/form-d/week/2010-01-25) · [All recent filings in Texas](https://specstream.ai/data/form-d/state/texas) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what HEMOBIOTECH, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).